Canada approves Moderna's RSV vaccine for adults aged 60 and older
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
The Gazette on MSN6d
Three years and waiting for Canada's made-in-Montreal COVID shot
Vaccine production is nearly three years behind schedule at a federally owned plant in Montreal and the future of a deal ...
Do COVID-19 boosters still make sense? What to know about the latest vaccine rollout
Canada’s panel of vaccine advisers has strongly recommended the new vaccines targeting the KP.2 strain, part of the Omicron lineage, for the previously vaccinated or unvaccinated at increased risk ...
Eagle-Tribune3d
Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older
mRESVIA is Moderna's second approved product in Canada, the first mRNA vaccine against RSV, and the only one in single-dose pre-filled syringes Canada is the fourth jurisdiction to approve ...
Updated COVID-19 vaccine available in Ontario as of today. Who is eligible, and where to get yours
Health officials say eligible residents can receive the COVID-19 vaccine at the same time as or at any time before or after ...
Mpox vaccine doses divvied up for 9 African countries
An initial 899,000 vaccine doses have been allocated for nine countries across Africa that have been hit hard by the current mpox surge, the WHO and other health organizations say.
Inside Canada's chaotic response to avian flu
Health Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older, available next year. A move by Quebec to allow a person with a serious ...
GlobalData on MSN4d
GSK’s RSV vaccine approved in Canada for adults aged 50 to 59
GlaxoSmithKline (GSK) has received approval for its vaccine, AREXVY, in Canada to prevent lower respiratory tract disease ...